Curacle Co., Ltd.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of CU06-1004 in Patients With Daibetic Macular Edema (NCT07459829) | Curacle Co., Ltd. | 2026-12-01 |
| Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis (NCT05907330) | Curacle Co., Ltd. | 2024-06-01 |
| Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria (NCT05718375) | Curacle Co., Ltd. | 2023-02-14 |
| The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME) (NCT05573100) | Curacle Co., Ltd. | 2022-12-21 |
| First-In-Human Study of CU06-1004 Following Single and Multiple Ascending Doses in Healthy Volunteers (NCT04795037) | Curacle Co., Ltd. | 2021-07-15 |
Track Curacle Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.